New frontiers in experimental methods for studying the tumor-immune microenvironment and cancer immunotherapy

The tumor-immune microenvironment (TIME) represents one of the most intricate and dynamic systems in modern biomedical research. Understanding the interplay between tumor and immune cells—such as cytotoxic T cells, regulatory T cells, macrophages, dendritic cells, and natural killer cells—is essential for unraveling mechanisms of tumor progression, immune evasion, and response to therapy. While major breakthroughs in cancer immunotherapy, from checkpoint blockade to CAR-T cell therapy, have transformed patient outcomes, methodological challenges persist. Standardized and validated experimental techniques that accurately capture immune function, spatial organization, and molecular signaling within tumors remain limited. Recent advances in omics technologies, spatial and high-dimensional cytometry, next-generation sequencing, and AI-assisted experimental design are enabling the development of more robust, reproducible, and translatable approaches for immune profiling and tumor characterization. However, the field still lacks harmonized standards and benchmarking frameworks that ensure comparability and reproducibility across studies—a gap this Research Topic seeks to address.This Research Topic aims to showcase and advance methodological innovations that enable deeper investigation of tumor-immune interactions and immunotherapeutic mechanisms. The key objective is to highlight new experimental strategies, platforms, and technologies that strengthen the reliability and generalizability of findings across cancer immunology research contexts. Specifically, it seeks contributions that focus on validated assays, instrumentation, reagents, and computationally guided experimental methods that reveal immune dynamics within the tumor microenvironment. By emphasizing the development of new tools rather than biological endpoints alone, this Research Topic aspires to accelerate translational progress, foster reproducibility, and contribute to the broader goal of improving health and well-being in alignment with SDG 3.This Research Topic focuses on methodological and technological innovations, not descriptive biological outcomes. Submissions should present generalizable advances in experimental design, validation, or application that drive the field of immunological research forward. To gather further insights, we welcome articles addressing, but not limited to, the following themes:o Pre-analytical considerations, sample handling, and reference standards for tumor-immune profilingo Novel assay platforms and experimental tools for characterizing immune cell function and mechanisms within the TIMEo High-dimensional immune profiling technologies: mass cytometry, spectral flow cytometry, single-cell omics, and spatial transcriptomics applied to cancer immunologyo Next-generation sequencing methods for analyzing TCR/BCR repertoires, neoantigen discovery, and immune gene expression in tumorso Enabling reagents and targeting modalities for experimental immunotherapy studies (e.g., immune checkpoint models, CAR-T technologies)o AI-assisted experimental immunology: machine learning tools that interpret, optimize, or accelerate immunological experiments in cancer researcho Standardized protocols and benchmarking frameworks for reproducible immunotherapy evaluation in experimental and preclinical models Topic editors: Masako Kinoshita, Kaushik Dehingia Source: https://www.frontiersin.org/research-topics/83427/new-frontiers-in-experimental-methods-for-studying-the-tumor-immune-microenvironment-and-cancer-immunotherapy